//--> //--> //-->
Toggle navigation
Logout
Change account settings
EN
DE
ES
FR
A-Z
Beta
About EconBiz
News
Thesaurus (STW)
Research Skills
Help
EN
DE
ES
FR
My account
Logout
Change account settings
Login
Publications
Events
Your search terms
Search
Retain my current filters
~source:"econstor"
Search options
All Fields
Title
Exact title
Subject
Author
Institution
ISBN/ISSN
Published in...
Publisher
Open Access only
Advanced
Search history
My EconBiz
Favorites
Loans
Reservations
Fines
You are here:
Home
Search: subject:"Tocilizumab"
Narrow search
Delete all filters
| 1 applied filter
Year of publication
From:
To:
Subject
All
Access to Medicines
2
Affordable Medicines
2
Biotherapeutics
2
COVID-19
2
Coronavirus
2
Favipiravir
2
Global Health
2
Health
2
Intellectual Property
2
Pandemic
2
Patent
2
Public Health
2
Remdesivir
2
Ruxolitinib
2
Sarilumab
2
Siltuximab
2
Tocilizumab
2
European Union (EU)
1
France
1
India
1
Molnupiravir
1
Nirmatrelvir
1
Patent Offices
1
United Nations Development Programme (UNDP)
1
United States (US)
1
World Intellectual Property Organization (WIPO)
1
more ...
less ...
Online availability
All
Free
2
Type of publication
All
Book / Working Paper
2
Type of publication (narrower categories)
All
Research Report
2
Language
All
English
2
Author
All
Ravi, Srividya
2
Published in...
All
Research Paper
2
Source
All
EconStor
ECONIS (ZBW)
2
Showing
1
-
2
of
2
Sort
relevance
articles prioritized
date (newest first)
date (oldest first)
1
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Ravi, Srividya
-
2022
biotherapeutics
tocilizumab
, siltuximab and sarilumab. …
Persistent link: https://www.econbiz.de/10013330854
Saved in:
2
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Ravi, Srividya
-
2020
patent analysis in this report are remdesivir, ruxolitinib and favipiravir, and the biotherapeutics
tocilizumab
, siltuximab …
Persistent link: https://www.econbiz.de/10012490900
Saved in:
Results per page
10
25
50
100
250
A service of the
zbw
×
Loading...
//-->